Impact of overweight and obesity on cardiac benefit of antihypertensive treatment.

  title={Impact of overweight and obesity on cardiac benefit of antihypertensive treatment.},
  author={Eva Gerdts and Giovanni de Simone and Barbara P Lund and Peter M. Okin and Kristian Wachtell and Kurt Boman and Markku S Nieminen and Bj{\"o}rn Dahl{\"o}f and Richard Blyton Devereux},
  journal={Nutrition, metabolism, and cardiovascular diseases : NMCD},
  volume={23 2},
BACKGROUND AND AIMS Increased body mass index (BMI) has been associated with increased cardiovascular morbidity and mortality in hypertension. Less is known about the impact of BMI on improvement in left ventricular (LV) structure and function during antihypertensive treatment. METHODS AND RESULTS Annual BMI, echocardiograms and cardiovascular events were recorded in 875 hypertensive patients with LV hypertrophy during 4.8 years randomized treatment in the Losartan Intervention For Endpoint… CONTINUE READING


Publications citing this paper.
Showing 1-9 of 9 extracted citations

Left ventricular hypertrophy and obesity: only a matter of fat?

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension • 2015
View 2 Excerpts